These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 14978666

  • 1. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
    Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB.
    Semin Arthritis Rheum; 2004 Feb; 33(4):283-8. PubMed ID: 14978666
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis.
    Arends S, Lebbink HR, Spoorenberg A, Bungener LB, Roozendaal C, van der Veer E, Houtman PM, Griep EN, Limburg PC, Kallenberg CG, Wolbink GJ, Brouwer E.
    Clin Exp Rheumatol; 2010 Feb; 28(5):661-8. PubMed ID: 20822711
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept.
    Rákóczi É, Perge B, Végh E, Csomor P, Pusztai A, Szamosi S, Bodnár N, Szántó S, Szücs G, Szekanecz Z.
    Joint Bone Spine; 2016 Dec; 83(6):675-679. PubMed ID: 26995488
    [Abstract] [Full Text] [Related]

  • 7. Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs.
    Crnkic Kapetanovic M, Saxne T, Truedsson L, Geborek P.
    Arthritis Res Ther; 2013 Jan 04; 15(1):R1. PubMed ID: 23286772
    [Abstract] [Full Text] [Related]

  • 8. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
    Kapetanovic MC, Roseman C, Jönsson G, Truedsson L, Saxne T, Geborek P.
    Arthritis Rheum; 2011 Dec 04; 63(12):3723-32. PubMed ID: 21834061
    [Abstract] [Full Text] [Related]

  • 9. Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.
    Kobie JJ, Zheng B, Bryk P, Barnes M, Ritchlin CT, Tabechian DA, Anandarajah AP, Looney RJ, Thiele RG, Anolik JH, Coca A, Wei C, Rosenberg AF, Feng C, Treanor JJ, Lee FE, Sanz I.
    Arthritis Res Ther; 2011 Dec 04; 13(6):R209. PubMed ID: 22177419
    [Abstract] [Full Text] [Related]

  • 10. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.
    De Rycke L, Baeten D, Kruithof E, Van den Bosch F, Veys EM, De Keyser F.
    Arthritis Rheum; 2005 Jul 04; 52(7):2192-201. PubMed ID: 15986349
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biologic therapies in the spondyloarthritis: new opportunities, new challenges.
    Braun J, Brandt J, Listing J, Rudwaleit M, Sieper J.
    Curr Opin Rheumatol; 2003 Jul 04; 15(4):394-407. PubMed ID: 12819466
    [Abstract] [Full Text] [Related]

  • 13. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
    Aikawa NE, França IL, Ribeiro AC, Sallum AM, Bonfa E, Silva CA.
    Vaccine; 2015 Jan 29; 33(5):604-9. PubMed ID: 25554240
    [Abstract] [Full Text] [Related]

  • 14. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept.
    Braun J, Baraliakos X, Listing J, Sieper J.
    Arthritis Rheum; 2005 Aug 29; 52(8):2447-51. PubMed ID: 16052578
    [Abstract] [Full Text] [Related]

  • 15. New indications for treatment of chronic inflammation by TNF-alpha blockade.
    Reimold AM.
    Am J Med Sci; 2003 Feb 29; 325(2):75-92. PubMed ID: 12589232
    [Abstract] [Full Text] [Related]

  • 16. Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept.
    Aghdashi MA, Khadir M, Dinparasti-Saleh R.
    Curr Rheumatol Rev; 2020 Feb 29; 16(1):61-66. PubMed ID: 31057111
    [Abstract] [Full Text] [Related]

  • 17. [Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis].
    Lanfant-Weybel K, Lequerré T, Vittecoq O.
    Presse Med; 2009 May 29; 38(5):774-87. PubMed ID: 19327945
    [Abstract] [Full Text] [Related]

  • 18. Ankylosing spondylitis and rheumatoid arthritis: serum levels of TNF-α and Its soluble receptors during the course of therapy with etanercept and infliximab.
    Schulz M, Dotzlaw H, Neeck G.
    Biomed Res Int; 2014 May 29; 2014():675108. PubMed ID: 24783218
    [Abstract] [Full Text] [Related]

  • 19. Drug survival rates of tumor necrosis factor inhibitors in patients with rheumatoid arthritis and ankylosing spondylitis.
    Kang JH, Park DJ, Lee JW, Lee KE, Wen L, Kim TJ, Park YW, Lee SS.
    J Korean Med Sci; 2014 Sep 29; 29(9):1205-11. PubMed ID: 25246737
    [Abstract] [Full Text] [Related]

  • 20. Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis.
    Fleischmann R, Iqbal I.
    Drugs Aging; 2007 Sep 29; 24(3):239-54. PubMed ID: 17362051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.